Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05WKQ
|
|||
| Former ID |
DNCL003674
|
|||
| Drug Name |
LAI287
|
|||
| Synonyms |
NN1436
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11] | Phase 3 | [1] | |
| Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 1 | [2] | ||
| Company |
Novo Nordisk
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04460885) A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 1). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.